Literature DB >> 8450037

Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells.

R Bacchetta1, B A Vandekerckhove, J L Touraine, M Bigler, S Martino, L Gebuhrer, J E de Vries, H Spits, M G Roncarolo.   

Abstract

We have studied the peripheral T cell repertoire of two patients with severe combined immunodeficiency who were successfully treated with human histocompatibility leukocyte antigen (HLA)-mismatched fetal liver stem cell transplantation. The patients presented a split chimerism. T cells were of donor origin, whereas the B cells/monocytes were of the host phenotype. Interestingly, the natural killer (NK) cells in one patient were donor derived and in the other patient of host origin. The NK cells were functional but did not have antihost or donor reactivity. Despite the HLA mismatch between donor and host cells, complete tolerance was achieved in vivo, and a specific unresponsiveness of peripheral blood mononuclear cells from both patients toward the host cells was demonstrated in vitro. Nevertheless, we could isolate T cell receptor (TCR)alpha beta, CD4+ or CD8+, T cell clones specifically reacting with HLA class I and II molecules of the host. The CD4+ host-reactive T cell clones from both patients produced interleukins 2 and 5, interferon-gamma, granulocyte/macrophage colony-stimulating factor but are specifically defective in interleukin 4 production. The frequencies of CD8+ host-reactive T cells were high, and were in the same range as those observed for CD8+ alloreactive T cells. In contrast, no donor-reactive CD8+ T cells or host or donor-reactive TCR gamma delta + T cells were detected. These data indicate that, after fetal stem cell transplantation, donor-reactive, but not host-reactive cells, are deleted from the T cell repertoire. Therefore, a peripheral mechanism of suppression or clonal anergy, rather than clonal deletion, is involved in maintaining in vivo tolerance toward the host.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8450037      PMCID: PMC288061          DOI: 10.1172/JCI116264

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

Review 1.  The developmental relationship between NK cells and T cells.

Authors:  L L Lanier; H Spits; J H Phillips
Journal:  Immunol Today       Date:  1992-10

2.  A T-cell receptor gamma/CD3 complex found on cloned functional lymphocytes.

Authors:  J Borst; R J van de Griend; J W van Oostveen; S L Ang; C J Melief; J G Seidman; R L Bolhuis
Journal:  Nature       Date:  1987 Feb 19-25       Impact factor: 49.962

3.  Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.

Authors:  R H Buckley; S E Schiff; H A Sampson; R I Schiff; M L Markert; A P Knutsen; M S Hershfield; A T Huang; G H Mickey; F E Ward
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

4.  Modified responses to recipient and donor B cells by genetically donor T cells from human haploidentical bone marrow chimeras.

Authors:  S E Schiff; R H Buckley
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

5.  Self-tolerance to host and donor following HLA-mismatched bone marrow transplantation.

Authors:  J P De Villartay; C Griscelli; A Fischer
Journal:  Eur J Immunol       Date:  1986-02       Impact factor: 5.532

6.  Cooperation between major histocompatibility complex mismatched mononuclear cells from a human chimera in the production of antigen-specific antibody.

Authors:  M G Roncarolo; J L Touraine; J Banchereau
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

7.  Immunodeficiency diseases and expression of HLA antigens.

Authors:  J L Touraine; H Bétuel
Journal:  Hum Immunol       Date:  1981-03       Impact factor: 2.850

8.  The T3/T cell receptor complex: antigenic distinction between the two 20-kd T3 (T3-delta and T3-epsilon) subunits.

Authors:  S Pessano; H Oettgen; A K Bhan; C Terhorst
Journal:  EMBO J       Date:  1985-02       Impact factor: 11.598

9.  Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection.

Authors:  W J Murphy; V Kumar; M Bennett
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

10.  Phenotype of recovering lymphoid cell populations after marrow transplantation.

Authors:  K A Ault; J H Antin; D Ginsburg; S H Orkin; J M Rappeport; M L Keohan; P Martin; B R Smith
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Stem cell transplantation for immunodeficiency.

Authors:  A Fischer; E Haddad; N Jabado; J L Casanova; S Blanche; F Le Deist; M Cavazzana-Calvo
Journal:  Springer Semin Immunopathol       Date:  1998

2.  Immunological lessons learnt from patients transplanted with fully mismatched stem cells.

Authors:  Jean-Louis Touraine; Hélène Plotnicky; Maria-Grazia Roncarolo; Rosa Bacchetta; Lucette Gebuhrer
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

3.  Expression of conformationally constrained adhesion peptide in an antibody CDR loop and inhibition of natural killer cell cytotoxic activity by an antibody antigenized with the RGD motif.

Authors:  M Zanetti; G Filaci; R H Lee; P del Guercio; F Rossi; R Bacchetta; F Stevenson; V Barnaba; R Billetta
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

4.  Transplantation tolerance induced in humans at the fetal or the neonatal stage.

Authors:  Jean-Louis Touraine; Kamel Sanhadji
Journal:  J Transplant       Date:  2011-08-18

5.  Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.

Authors:  H Groux; M Bigler; J E de Vries; M G Roncarolo
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

Review 6.  In utero hematopoietic cell transplantation: induction of donor specific immune tolerance and postnatal transplants.

Authors:  William H Peranteau
Journal:  Front Pharmacol       Date:  2014-11-12       Impact factor: 5.810

Review 7.  Immunological considerations in in utero hematopoetic stem cell transplantation (IUHCT).

Authors:  Andrea I Loewendorf; Marie Csete; Alan Flake
Journal:  Front Pharmacol       Date:  2015-01-06       Impact factor: 5.810

8.  High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.

Authors:  R Bacchetta; M Bigler; J L Touraine; R Parkman; P A Tovo; J Abrams; R de Waal Malefyt; J E de Vries; M G Roncarolo
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.